Minimally invasive coronary bypass grafting for treating multivessel coronary disease: A single-center prospective pilot study

Tong Ding, Yichen Gong, Yuanhao Fu, Zhongqi Cui, Song Wu, Wei Yang, Hang Yang, Hong Zhao, Haibo Feng, Huiping Zheng, Liesu Meng, Rui Guo, Hui Han, Yunpeng LingJTCVS 2025 · DOI

Abstract

MICS-CABG, an emerging modality for treating multivessel coronary disease, yields an improved 7- and 30-day physical function than off-pump coronary artery bypass. Moreover, both strategies resulted in similar significant relief from angina over 12 months. A randomized controlled trial is warranted to compare the efficacy of these 2 revascularization strategies. (Prospective Cohort Study on Minimal Invasive Coronary Surgery: NCT04267835).
BibTeX
@inproceedings{ding2025minimally,
  author = {Tong Ding and Yichen Gong and Yuanhao Fu and Zhongqi Cui and Song Wu and Wei Yang and Hang Yang and Hong Zhao and Haibo Feng and Huiping Zheng and Liesu Meng and Rui Guo and Hui Han and Yunpeng Ling},
  title = {{Minimally invasive coronary bypass grafting for treating multivessel coronary disease: A single-center prospective pilot study}},
  booktitle = {JTCVS},
  year = {2025},
  doi = {10.1016/j.xjon.2025.03.030},
}

Loading related content...

Figure